CORC

在结果中检索

CORC

浏览/检索结果: 共101条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Ultra-wideband solar absorber based on refractory titanium metal 会议论文
作者:  Yu, Peiqi;  Yang, Hua;  Chen, Xifang;  Yi, Zao;  Yao, Weitang
收藏  |  浏览/下载：10/0  |  提交时间：2020/12/18
A dual-band metamaterial absorber for graphene surface plasmon resonance at terahertz frequency 会议论文
作者:  Cen, Chunlian;  Zhang, Yubin;  Chen, Xifang;  Yang, Hua;  Yi, Zao
收藏  |  浏览/下载：5/0  |  提交时间：2020/12/18
Co-enhancement of oxidation resistance and mechanical properties of Cf/LAS composites: The effects of h-BN addition 会议论文
作者:  Wu, Songsong;  Dingd, Chuanyan;  Ma, Guansheng;  Xia, Long;  Hou, Yongzhao
收藏  |  浏览/下载：6/0  |  提交时间：2020/12/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：143/0  |  提交时间：2019/12/02
Addressing the Under-translation Problem from the Entropy Perspective 会议论文
Honolulu, Hawaii, USA, 2019
作者:  Zhao, Yang;  Zhang, Jiajun;  Zong, Chengqing;  He, Zhongjun;  Wu, Hua
收藏  |  浏览/下载：152/0  |  提交时间：2019/02/25
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
PSYCHOLOGICAL PROFILE IN PATIENTS WITH RHEUMATIC DISEASES IN CHINA: A STUDY OF HADS SELF-ASSESSMENT WITH SMART SYSTEM OF DISEASE MANAGEMENT (SSDM) 会议论文
作者:  Wang, Yongfu;  Li Yang;  Li Yasong;  Hua Wei;  Wu, Henglian
收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace